David W. Ghesquiere
Corporate Officer/Principal chez NANOSTRING TECHNOLOGIES, INC.
Profil
David W.
Ghesquiere is the founder of Adrenaline Venture & Advisory LLC, founded in 2012, where he held the title of Managing Director.
He is currently the Senior VP-Corporate & Business Development at NanoString Technologies, Inc. since 2013.
Mr. Ghesquiere's former positions include Director-Global Business Development at Aventis Pharmaceuticals, Inc. from 2000 to 2005, Senior VP-Corporate & Business Development at OSI Pharmaceuticals, Inc. from 2005 to 2010, Secretary, Director & Managing Director at OSI Investment Management GmbH from 2009 to 2010, Secretary, Director & Managing Director at Osi Investment Holdings GmbH from 2009 to 2010, and Senior VP-Corporate & Business Development at Dendreon Corp.
from 2011 to 2012.
Mr. Ghesquiere's education includes an undergraduate degree from the University of Western Ontario and an MBA degree from Richard Ivey School of Business.
Postes actifs de David W. Ghesquiere
| Sociétés | Poste | Début |
|---|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Corporate Officer/Principal | 29/11/2013 |
Anciens postes connus de David W. Ghesquiere
| Sociétés | Poste | Fin |
|---|---|---|
Adrenaline Venture & Advisory LLC
 Adrenaline Venture & Advisory LLC Investment ManagersFinance Adrenaline Venture & Advisory LLC provides investment advisory services. The private company is based in Seattle, WA. The company was founded by David W. Ghesquiere. | Chief Executive Officer | 01/11/2013 |
| DENDREON CORPORATION | Corporate Officer/Principal | 01/01/2012 |
| Osi Investment Holdings GmbH | Director/Board Member | 01/12/2010 |
| OSI Investment Management GmbH | Director/Board Member | 01/12/2010 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2010 |
Formation de David W. Ghesquiere
| University of Western Ontario | Undergraduate Degree |
| Richard Ivey School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
| OSI Investment Management GmbH | |
| Osi Investment Holdings GmbH | |
Adrenaline Venture & Advisory LLC
Adrenaline Venture & Advisory LLC Investment ManagersFinance Adrenaline Venture & Advisory LLC provides investment advisory services. The private company is based in Seattle, WA. The company was founded by David W. Ghesquiere. | Finance |
